ATHA (Athira Pharma Inc) Net Profit

Official company branding of Athira Pharma (ATHA)

Early-stage research failure risks and a lack of funds following restructuring are weighing on Athira Pharma, Inc. (ATHA). However, Athira Pharma, Inc. (ATHA) is developing promising small molecules for neuron regeneration in Alzheimer's disease. The strategy is based on the activation of the HGF/MET system to combat dementia. The company's bottom line demonstrates profit dynamics, where -0.04 forms the current metric indicator.

Athira Pharma Corp (ATHA) - Net Profit from 07/04/2022 to 01/12/2026

Analytical breakdowns and data insights for company Athira Pharma (ATHA)

- stock value and consensus price forecast:
Market Price Athira Pharma Corp|ATHA - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Athira Pharma Corp|ATHA - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Athira Pharma|ATHA - Book Capitalization|Market Value to Book Value athira.com|ATHA - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient Athira Pharma, Inc.|ATHA - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Athira Pharma Inc|ATHA - Company Aggregate Debts|Debts to Book Capitalization Athira Pharma Corp|ATHA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Athira Pharma|Critical Liquidity Ratio athira.com
- earnings and valuation multiples indicators:
ATHA - Net Profit
Fundamental valuation:Athira Pharma, Inc.
Mass-produced product of Athira Pharma Inc

This metric measures actual cash flow, making it possible to determine whether the rise in quotes is supported by a real increase in revenue or is speculative. Analyzing the net profit trend of Athira Pharma, Inc. (ATHA) is critical for stress-testing assets, as the current shift in R&D strategy following failures with the lead drug makes the search for stable income sources a priority for restoring investor confidence.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Net Income AXSM (Axsome Therapeutics, Inc.)|Profit After Payment of Taxes ACAD|Net Profit XENE (Xenon Pharmaceuticals Inc)|Final Profit VKTX|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Company Net Income|Harmony Biosciences Inc - Final Profit|BHVN (Biohaven Pharmaceutical) - Net Profit|Net Profit Amylyx Corp|Net Income TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Final Profit|Company Net Income Anavex Life Sciences Corp. AVXL|CBLL (CeriBell Inc) - Profit After Tax|Prothena Biosciences - Net Profit|Final Profit ALEC (Alector, Inc.)|ANNX: Net Profit|Omeros (OMER) - Net Profit|Company Net Income Neurogene|ACIU: Final Profit|Company Net Income Voyager Pharma (VYGR)|Net Income Neumora Corp NMRA|Net Profit SCLX (Scilex Holding Company)|Net Profit tevogen.com TVGN|ACOG: Net Income|Final Profit CGTX (cogrx.com)|IKT: Net Profit|SAVA - Net Financial Result|Company Net Income Assertio Holdings|Company Profit COYA (Coya)|Net Profit VTGN|Net Income ovidrx.com OVID|Acumen Pharma - Net Income|Net Financial Result CervoMed Corporation (CRVO)|Alterity Therapeutics Ltd - Net Profit|CLNN - Net Profit|PEPG (pepgen.com) - Net Income|JUNS: Profit After Payment of Taxes|RLMD (Relmada) - Net Profit|ANVS: Final Profit|Net Profit GRCE|Net Profit fireflyneuro.com (AIFF)|Company Net Income Klotho Neurosciences KLTO|NRSN: Company Profit|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|NRXS (NeurAxis, Inc.) - Net Income|Helius Medical Technologies (HSDT) - Net Profit|Company Net Income Passage Bio Inc.|NEUP: Final Profit|Company Net Income Minerva Neurosciences Corp (NERV)|ADXN - Company Net Income|Net Profit ALZN (Alzamend Neuro)|Net Profit Cyclerion Therapeutics Inc. CYCN|PTIX: Net Income|Pasithea Therapeutics - Profit After Payment of Taxes|CRGT: Net Profit|Avenue Therapeutics Inc - Final Profit|BCLI (Brainstorm Cell) - Net Profit|caratherapeutics.com (CARA) - Net Financial Result|Company Net Income Chromocell Therapeutics Corp. (CHRO)|ELYM (eliemtx.com) - Final Profit|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|Net Profit Longboard LBPH|MRNS: Net Income|Final Profit NKGN (nkgenbiotech.com)|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Profit After Tax SAGE (Sage Therapeutics Inc.)|SNPX (Neurotrope) - Net Profit|TRVN: Final Profit|Net Profit VIGL|Net Profit Anew Medical Inc. (WENA)|Company Net Income Cerevel Therapeutics, Inc. CERE